NCT02435563View on ClinicalTrials.gov

Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

ticagrelor 180 mg administrated alone

DRUG

Ticagrelor adjusted dose + ritonavir 100mg

Trial Locations (1)

1211

Centre de Recherche Clinique, HUG, Rue Gabrielle Perret-Gentil 4, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT02435563 - Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling | Biotech Hunter | Biotech Hunter